Communications
In a rapidly evolving digital ecosystem, the pharmaceutical industry’s relationship with content is undergoing a seismic shift. At the recent Reuters Pharma event in Barcelona, Dr. Namrata, Founder of Turacoz, led a thought-provoking panel discussion titled ‘Content’s Industrial Revolution’. The dialogue explored how content in pharma is undergoing a transformation driven by technology, collaboration, and an evolving mindset.
This transformation isn’t just about producing more content – it’s about producing smarter content that is personalized, compliant, and delivered at speed and scale. Here are the key takeaways that highlight how pharma companies can adapt to this revolution.
From linear to circular: Rethinking the content supply chain
Traditionally, the content supply chain in pharma has been linear – ideation, creation, review, and deployment. But the industry is waking up to a powerful realization: a circular content supply chain is the way forward. This means insights from content consumption must loop back into content creation.
It’s about listening, learning, and evolving continuously. When feedback and performance metrics inform the next content iteration, the result is more relevant, targeted, and effective communication.
Upfront partnerships: Shifting left in the review process
Another game-changing approach discussed in the panel was the concept of “shifting left” – engaging reviewers early in the content lifecycle. Instead of waiting until the end of the process for medical, legal, and regulatory (MLR) reviews, involving them upfront leads to fewer iterations and a higher rate of getting content right the first time. “Involving reviewers early and leveraging AI is no longer optional—it’s the only way to create content that’s both fast and flawless,” noted Dr. Namrata during the panel. This proactive alignment improves efficiency, saves time, and ensures clarity from the start.
AI and GenAI in Action: Smarter, Faster, Compliant
Nearly 80% of pharma companies are now embedding AI into their content workflows.1 The path forward lies in industrialization—standardizing content processes to eliminate duplication and reduce costs. This includes:
These innovations reduce manual effort and error, speed up reviews and improve compliance and traceability.
Reduce, reuse, recycle: Sustainable content practices
Content sustainability is now a business imperative. Strategies like modular content creation, centralized digital libraries, and approved content recycling help reduce production time and content fatigue—while ensuring consistency across global teams.
Let’s break down what reduce, reuse, and recycle means in the pharma content world:
These sustainable practices improve efficiency, maintain global consistency, and cut down costs.
Mindset, toolset, and skillset: The three pillars of change
Technology is only part of the equation. To truly embrace this revolution, organizations need the right:
Internal and external collaboration will be the glue that holds these pillars together ensuring that strategy, execution, and innovation move in sync.
Human + Machine: A balanced equation
While technology is a powerful enabler, the human touch remains irreplaceable. Keeping humans in the loop ensures contextual accuracy, emotional intelligence, and ethical responsibility especially critical in healthcare communications. The goal is to strike the right balance between automation and human oversight.
Final thoughts
As the content landscape shifts from volume to value, pharma companies need to focus on crafting impactful content that resonates with the audience. This means not just doing things faster but doing them better – with clarity, compliance, and compassion.
At Turacoz, we are proud to be at the forefront of this transformation, driving change that empowers our clients to communicate with precision and purpose. The content revolution is here—and we’re ready to lead it.
Ready to transform your content strategy? Connect with Turacoz to explore how we can help you scale smarter.
Reference:
Kudumala A, Konersmann T, Israel A, Miranda W. Biopharma digital transformation: Gain an edge with leapfrog digital innovation. Deloitte Insights. 2021 Dec 8. Available from: https://www2.deloitte.com/us/en/insights/industry/life-sciences/biopharma-digital-transformation.html
“Write the paper as though no editor will ever see it … then let a good editor make sure everyone
World Thyroid Day invites us to appreciate the tiny, butterfly-shaped gland with a big job in managing our body’s energy,
In an era where speed, efficiency, and personalization have become imperatives, Artificial Intelligence (AI) — particularly machine learning, AI algorithms,
Every 8 May, World Thalassemia Day shines an international spotlight on the millions of people living with this inherited genetic disorder.
Ovarian cancer remains one of the most challenging gynaecologic malignancies, often referred to as a “silent killer” due to its subtle onset and late-stage diagnosis.1 In 2022, 324,603 women worldwide were diagnosed with ovarian cancer.
The healthcare landscape is being reshaped at an unprecedented pace, powered by sophisticated data analytics, emerging technologies, and the escalating
Biosimilars—biologic medicines that are highly similar to FDA-approved originator biologics—offer a cost-effective alternative without compromising clinical efficacy.1,2 Since the first
By Turacoz Healthcare Solutions | World Liver Day 2025 In a world where social media dominates wellness discussions, liver health
The healthcare industry is experiencing a paradigm shift as patient voices take center stage in drug development and approval processes.
In the evolving era of healthcare, data is the foundation of informed decision-making. With the rise of Artificial Intelligence (AI)
Partner with Turacoz to bring science to life through strategic and evidence-based communication.